Abstract
To evaluate the effects of dipyridamole on blood platelet function in patients with coronary artery disease, platelet counts and aggregation were examined in aortic and coronary venous blood. Before administration of dipyridamole, platelet counts and aggregation in response to adenosine diphosphate were less (p less than 0.02) in coronary venous than in aortic blood. Dipyridamole administration (100 mg) resulted in an increase in platelet counts and platelet aggregation in coronary venous blood so that the differences in aortic and coronary venous blood values were eliminated. These phenomena were probably related to inhibitory actions of dipyridamole on platelet adhesion to atherosclerotic vessels. To further study the mechanism of action, the direct effects of dipyridamole on in vitro platelet aggregation were evaluated. Although dipyridamole, in the concentrations used, had no effect on in vitro platelet aggregation, it greatly potentiated the aggregation inhibitory actions of exogenous prostacyclin. In vivo potentiation of endogenous prostacyclin and inhibitory actions on platelet adhesion are the most likely mechanisms of the potentially beneficial actions of dipyridamole.
References
Mar 1, 1977·Circulation Research·W I Rosenblum, F El-Sabban
Jan 1, 1979·Thrombosis Research·L C BestR G Russell
Jul 1, 1979·Progress in Cardiovascular Diseases·A I Schafer, R I Handin
Nov 1, 1978·Circulation·J MehtaC J Pepine
Jan 1, 1976·Drugs·A S Gallus, J Hirsh
Apr 1, 1977·British Journal of Clinical Pharmacology·S M RajahD A Watson
Sep 1, 1976·Circulation·J D FoltsG G Rowe
Jul 1, 1973·American Heart Journal·C B MoschosT J Regan
Oct 1, 1973·The American Journal of Cardiology·N Salky, M Dugdale
Mar 7, 1974·The New England Journal of Medicine·H S WeilyE Genton
Jun 24, 1971·The New England Journal of Medicine·J M SullivanR Gorlin
Nov 1, 1970·Circulation·H S Weily, E Genton
Dec 10, 1970·The New England Journal of Medicine·L A Harker, S J Slichter
Citations
Jan 1, 1985·European Journal of Clinical Pharmacology·I MelamedZ Spirer
Dec 1, 1982·Prostaglandins·J MehtaD Hay
Oct 1, 1987·British Journal of Clinical Pharmacology·D GregovJ Lloyd
Oct 3, 2002·Current Opinion in Cardiology·Paulette Mehta
Jan 1, 1981·Acta Medica Scandinavica. Supplementum·J Mehta, P Mehta
Nov 1, 1984·Drug Intelligence & Clinical Pharmacy·M P RiveyJ W Taylor
Feb 1, 1986·Current Problems in Cardiology·W H Frishman, K P Miller
May 1, 1994·Kidney International·R SreedharaR M Hakim